Finance

Beta
Lists
4018:TADAWUL
Almoosa Health Company SJSC
SAR 119.00
-0.17%
(-0.20) 1D
Jun 4, 3:16:49 PM GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 4018...
Open
SAR 119.20
High
SAR 119.80
Low
SAR 118.70
Mkt. cap
5.27B
Avg. vol.
44.75K
Volume
12.17K
Dividend
1.09%
Quarterly dividend
SAR 0.32
Ex-dividend date
May 18, 2026
P/E ratio
25.15
52-wk high
SAR 212.00
52-wk low
SAR 110.00
EPS
SAR 4.73
Shares outstanding
15.17M
No. of employees
0
Open
SAR 119.20
High
SAR 119.80
Low
SAR 118.70
Mkt. cap
5.27B
Avg. vol.
44.75K
Volume
12.17K
Dividend
1.09%
Quarterly dividend
SAR 0.32
Ex-dividend date
May 18, 2026
P/E ratio
25.15
52-wk high
SAR 212.00
52-wk low
SAR 110.00
EPS
SAR 4.73
Shares outstanding
15.17M
No. of employees
0
News stories
From sources across the web
About Almoosa Health Company SJSC
CEO-
Employees0
Founded1994
Headquarters-
SectorHealth care provider
Previous reportsAll values in SAR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SAR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
348.97M
356.38M
387.96M
348.33M
Cost of goods sold
236.88M
238.95M
293.17M
251.31M
Cost of revenue
236.88M
238.95M
293.17M
251.31M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
57.02M
65.55M
46.70M
60.34M
Operating expense
57.68M
60.38M
36.76M
56.97M
Total operating expenses
294.55M
299.32M
329.93M
308.28M
Operating income
54.41M
57.06M
58.03M
40.05M
Other non operating income
2.16M
-
29.84M
-13.29M
EBT including unusual items
52.54M
52.74M
87.35M
24.67M
EBT excluding unusual items
52.54M
52.74M
87.14M
23.91M
Income tax expense
762.56K
1.10M
5.35M
1.16M
Effective tax rate
1.45%
2.09%
6.12%
4.70%
Other operating expenses
-265.78K
-6.07M
-14.07M
-4.77M
Net income
51.77M
51.64M
82.00M
23.51M
Net profit margin
14.84%
14.49%
21.14%
6.75%
Earnings per share
-
-
-
0.51
Interest and investment income
-
1.10M
861.30K
781.67K
Interest expense
-3.99M
-5.77M
-1.77M
-3.73M
Net interest expenses
-3.99M
-4.67M
-908.25K
-2.95M
Depreciation and amortization charges
-
-
-
-
EBITDA
75.61M
78.57M
79.96M
64.65M
Gain or loss from assets sale
-6.00K
-28.96K
-169.70K
-6.95K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more